Vicarious Surgical (RBOT) Stock Forecast & Price Target

RBOT Forecast - Frequently Asked Questions

What is Vicarious Surgical's forecast for 2025?

According to the research reports of 2 Wall Street equities research analysts, the average twelve-month stock price forecast for Vicarious Surgical is $10.25, with a high forecast of $10.50 and a low forecast of $10.00.

Should I buy or sell Vicarious Surgical stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Vicarious Surgical in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" RBOT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RBOT, but not buy additional shares or sell existing shares.

Does Vicarious Surgical's stock price have much downside?

According to analysts, Vicarious Surgical's stock has a predicted downside of -14.58% based on their 12-month stock forecasts.

What analysts cover Vicarious Surgical?

Vicarious Surgical has been rated by research analysts at Piper Sandler in the past 90 days.

Do Wall Street analysts like Vicarious Surgical more than its competitors?

Analysts like Vicarious Surgical less than other "medical" companies. The consensus rating for Vicarious Surgical is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how RBOT compares to other companies.